In people with obesity, insulin clearance is significantly decreased and inversely associated with insulin resistance in the liver, muscle, and adipose tissue; lower insulin clearance may be an important compensatory mechanism that contributes to hyperinsulinemia in these clinical conditions (135). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.